ProfileGDS4718 / 207773_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 48% 50% 42% 43% 47% 37% 43% 46% 60% 50% 49% 47% 51% 45% 44% 39% 51% 45% 43% 45% 43% 46% 44% 47% 51% 44% 55% 37% 45% 43% 53% 42% 49% 50% 46% 43% 42% 50% 49% 38% 57% 42% 43% 37% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4176248
GSM549102patient 115, normal, homogenized [OPG study]5.5152750
GSM549104patient 119, normal, homogenized [OPG study]5.0548442
GSM549108patient 138, normal, homogenized [OPG study]5.215943
GSM549119patient 077, normal, homogenized [OPG study]5.3364447
GSM549133patient 032, cancer, homogenized [OPG study]4.7984737
GSM549139patient 042, cancer, homogenized [OPG study]5.1379643
GSM549099patient 107, normal, homogenized [OPG study]5.3032446
GSM549109patient 139, normal, homogenized [OPG study]6.1613160
GSM549110patient 046, normal, homogenized [OPG study]5.5268450
GSM549114patient 063, normal, homogenized [OPG study]5.4161249
GSM549122patient 082, normal, homogenized [OPG study]5.36747
GSM549134patient 033, cancer, homogenized [OPG study]5.5555751
GSM549136patient 036, cancer, homogenized [OPG study]5.1628145
GSM549140patient 044, cancer, homogenized [OPG study]5.1648444
GSM549111patient 047, normal, homogenized [OPG study]4.9039539
GSM549113patient 057, normal, homogenized [OPG study]5.5237351
GSM549132patient 031, cancer, homogenized [OPG study]5.2336745
GSM549137patient 038, cancer, homogenized [OPG study]5.1416143
GSM549142patient 047, cancer, homogenized [OPG study]5.3889345
GSM549100patient 110, normal, homogenized [OPG study]5.166543
GSM549107patient 135, normal, homogenized [OPG study]5.2685646
GSM549115patient 068, normal, homogenized [OPG study]5.1351944
GSM549116patient 072, normal, homogenized [OPG study]5.3342347
GSM549120patient 078, normal, homogenized [OPG study]5.5878951
GSM549131patient 030, cancer, homogenized [OPG study]5.1076344
GSM549118patient 074, normal, homogenized [OPG study]5.793555
GSM549129patient 027, cancer, homogenized [OPG study]4.8604237
GSM549123patient 088, normal, homogenized [OPG study]5.2073445
GSM549124patient 006, cancer, homogenized [OPG study]5.1724443
GSM549126patient 015, cancer, homogenized [OPG study]5.6797453
GSM549128patient 025, cancer, homogenized [OPG study]5.0777142
GSM549103patient 117, normal, homogenized [OPG study]5.4875249
GSM549117patient 073, normal, homogenized [OPG study]5.4937850
GSM549138patient 041, cancer, homogenized [OPG study]5.260846
GSM549141patient 045, cancer, homogenized [OPG study]5.062743
GSM549130patient 028, cancer, homogenized [OPG study]5.1198442
GSM549101patient 111, normal, homogenized [OPG study]5.5191350
GSM549105patient 128, normal, homogenized [OPG study]5.4749849
GSM549106patient 134, normal, homogenized [OPG study]4.8696538
GSM549112patient 048, normal, homogenized [OPG study]5.8930457
GSM549125patient 011, cancer, homogenized [OPG study]5.0915942
GSM549127patient 024, cancer, homogenized [OPG study]5.1505543
GSM549135patient 035, cancer, homogenized [OPG study]4.8137537